Filing Flows › Bristol Myers Squibb (BMY) › Operating margin
Bristol Myers Squibb (BMY) operating margin by quarter
Bristol Myers Squibb's operating margin was 19.4% in Q3 2026 (third quarter 2026), -12.1 pts from Q2 2026. Over the last 7 quarters it ranged from 11.8% (Q4 2025) to 31.5% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 19.4% | -12.1 pts | -6.1 pts |
| Q2 2026 | 31.5% | +3.3 pts | +17.0 pts |
| Q1 2026 | 28.2% | +16.4 pts | +1.7 pts |
| Q4 2025 | 11.8% | -13.7 pts | — |
| Q3 2025 | 25.5% | +11.0 pts | — |
| Q2 2025 | 14.5% | -12.1 pts | — |
| Q1 2025 | 26.5% | — | — |
Q3 2026 at a glance
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Bristol Myers Squibb's operating margin?
Bristol Myers Squibb's operating margin was 19.4% in Q3 2026 (third quarter 2026), -12.1 pts from Q2 2026.
How has Bristol Myers Squibb's operating margin changed?
Over the last 7 quarters it ranged from 11.8% (Q4 2025) to 31.5% (Q2 2026).